Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 octubre 2015

NEUROSURGERY. Appropriate Use of Limited Interventions vs Extensive Surgery in the Elderly Patient With Spinal Disorders

Gussous, Yazeed MD*; Than, Khoi MD‡; Mummaneni, Praveen MD‡; Smith, Justin MD, PhD§; Steinmetz, Michael MD¶; Ohya, Junichi MD*; Berven, Sigurd MD*

Abstract: Surgical management of spinal deformity is elderly patients is characterized by significant variability. In a value-based health care economy, minimization of risks and maximization of benefit and durability of surgery are a priority. The choice of a surgical approach is a significant determinant of risk, cost, and outcome. Informed choice regarding a surgical approach requires participation of the patient and surgeon. Limited interventions may be appropriate for patients with radicular symptoms and focal pain.

01 octubre 2015

NEUROSURGERY. Impact of Movement Disorders on Management of Spinal Deformity in the Elderly

Ha, Yoon MD, PhD*,‡; Oh, Jae Keun MD*,‡,§; Smith, Justin S. MD, PhD¶; Ailon, Tamir MD, MPH¶,§; Fehlings, Michael G. MD, PhD‖; Shaffrey, Christopher I. MD¶,§; Ames, Christopher P. MD#

Abstract: Spinal deformities are frequent and disabling complications of movement disorders such as Parkinson disease and multiple system atrophy. The most distinct spinal deformities include camptocormia, antecollis, Pisa syndrome, and scoliosis. Spinal surgery has become lower risk and more efficacious for complex spinal deformities, and thus more appealing to patients, particularly those for whom conservative treatment is inappropriate or ineffective. Recent innovations and advances in spinal surgery have revolutionized the management of spinal deformities in elderly patients.

20 julio 2016

SPRINGER. Determinants of leptomeningeal collateral flow in stroke patients with a middle cerebral artery occlusion

Tom van Seeters, Geert Jan BiesselsL. Jaap KappelleYolanda van der GraafBirgitta K. Velthuison behalf of the Dutch acute stroke study (DUST) investigators

Introduction: Poor leptomeningeal collateral flow is related to worse clinical outcome in acute ischemic stroke, but the factors that determine leptomeningeal collateral patency are largely unknown. We explored the determinants of leptomeningeal collateral flow and assessed their effect on the relation between leptomeningeal collateral flow and clinical outcome.

28 abril 2016

AMERICAN JOURNAL OF NEURORADIOLOGY. Application of Blood-Brain Barrier Permeability Imaging in Global Cerebral Edema

J. Ivanidze, O.N. Kallas, A. Gupta, E. Weidman, H. Baradaran, D. Mir, A. Giambrone, A.Z. Segal, J. Claassen and P.C. Sanelli

BACKGROUND AND PURPOSE: Blood-brain barrier permeability is not routinely evaluated in the clinical setting. Global cerebral edema occurs after SAH and is associated with BBB disruption. Detection of global cerebral edema using current imaging techniques is challenging. Our purpose was to apply blood-brain barrier permeability imaging in patients with global cerebral edema by using extended CT perfusion.

01 agosto 2015

STROKE. Embolic Strokes of Undetermined Source in the Athens Stroke Registry. An Outcome Analysis

George Ntaios, Vasileios Papavasileiou, Haralampos Milionis, Konstantinos Makaritsis, Anastasia Vemmou, Eleni Koroboki, Efstathios Manios, Konstantinos Spengos, Patrik Michel and Konstantinos Vemmos

Background and Purpose: Information about outcomes in Embolic Stroke of Undetermined Source (ESUS) patients is unavailable. This study provides a detailed analysis of outcomes of a large ESUS population.

01 agosto 2015

STROKE. Cerebral Microbleeds Predict Intracerebral Hemorrhage in Hemodialysis Patients

Toshihide Naganuma, Yoshiaki Takemoto, Tetsuo Shoji, Eiji Ishimura, Mikio Okamura and Tatsuya Nakatani

Background and Purpose: In hemodialysis patients, previous reports have described a high prevalence of cerebral microbleeds (CMBs), but no longitudinal studies have been performed to determine the clinical significance of CMBs in these patients. In this study, we investigated whether the presence of CMBs was a predictor of future strokes in hemodialysis patients.

01 agosto 2015

STROKE. Systolic Blood Pressure Control and Mortality After Stroke in Hypertensive Patients

Peter M. Okin, Sverre E. Kjeldsen and Richard B. Devereux

Background and Purpose: Hypertensive patients with electrocardiographic left ventricular hypertrophy are at increased risk of all-cause and cardiovascular death. Lowering blood pressure (BP) after stroke reduces the risk of recurrent stroke, but recent data suggest that lower systolic BP (SBP) measured 5 years after stroke is associated with increased mortality. Whether lower SBP is associated with increased short-term mortality after stroke in hypertensive patients is unclear.

01 agosto 2015

STROKE. White Matter Lesions Double the Risk of Post-Thrombolytic Intracerebral Hemorrhage

Sami Curtze, Elena Haapaniemi, Susanna Melkas, Satu Mustanoja, Jukka Putaala, Tiina Sairanen, Gerli Sibolt, Marjaana Tiainen, Turgut Tatlisumak and Daniel Strbian

Background and Purpose: Cerebral white matter lesions (WMLs), a surrogate for small-vessel disease, are common in patients with stroke and may be related to an increased intracranial bleeding risk after intravenous thrombolysis in acute ischemic stroke. We aimed to investigate the risk of symptomatic intracerebral hemorrhage (sICH) in the presence of WMLs in a large cohort of ischemic stroke patients treated with intravenous thrombolysis.

01 agosto 2015

STROKE. Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation. Effect of Anticoagulation and Its Timing: The RAF Study

Maurizio Paciaroni, Giancarlo Agnelli, Nicola Falocci, Valeria Caso, Cecilia Becattini, Simona Marcheselli, Christina Rueckert, Alessandro Pezzini, Loris Poli, Alessandro Padovani, Laszló Csiba, Lilla Szabó, Sung-Il Sohn, Tiziana Tassinari, Azmil H. Abdul-Rahim, Patrik Michel, Maria Cordier, Peter Vanacker, Suzette Remillard, Andrea Alberti, Michele Venti, Umberto Scoditti, Licia Denti, Giovanni Orlandi, Alberto Chiti, Gino Gialdini, Paolo Bovi, Monica Carletti, Alberto Rigatelli, Jukka Putaala, Turgut Tatlisumak, Luca Masotti, Gianni Lorenzini, Rossana Tassi, Francesca Guideri, Giuseppe Martini, Georgios Tsivgoulis, Kostantinos Vadikolias, Chrissoula Liantinioti, Francesco Corea, Massimo Del Sette, Walter Ageno, Maria Luisa De Lodovici, Giorgio Bono, Antonio Baldi, Sebastiano D’Anna, Simona Sacco, Antonio Carolei, Cindy Tiseo, Monica Acciarresi, Cataldo D’Amore, Davide Imberti, Dorjan Zabzuni, Boris Doronin, Vera Volodina, Domenico Consoli, Franco Galati, Alessio Pieroni, Danilo Toni, Serena Monaco, Mario Maimone Baronello, Kristian Barlinn, Lars-Peder Pallesen, Jessica Kepplinger, Ulf Bodechtel, Johannes Gerber, Dirk Deleu, Gayane Melikyan, Faisal Ibrahim, Naveed Akhtar, Maria Giulia Mosconi, Valentina Bubba, Ilenia Silvestri and Kennedy R. Lees

Background and Purpose: The best time for administering anticoagulation therapy in acute cardioembolic stroke remains unclear. This prospective cohort study of patients with acute stroke and atrial fibrillation, evaluated (1) the risk of recurrent ischemic event and severe bleeding; (2) the risk factors for recurrence and bleeding; and (3) the risks of recurrence and bleeding associated with anticoagulant therapy and its starting time after the acute stroke.

01 agosto 2015

STROKE. Socioeconomic Inequalities in the Prescription of Oral Anticoagulants in Stroke Patients With Atrial Fibrillation

Maria Sjölander, Marie Eriksson, Kjell Asplund, Bo Norrving and Eva-Lotta Glader

Background and Purpose: Oral anticoagulants (OACs) are effective against ischemic stroke in patients with atrial fibrillation. Our aim was to investigate differences in the prescribing of OACs after ischemic stroke in patients with atrial fibrillation based on age, sex, country of birth, and socioeconomic status.

01 agosto 2015

STROKE. Methods of Implementation of Evidence-Based Stroke Care in Europe. European Implementation Score Collaboration

Antonio Di Carlo, Francesca Romana Pezzella, Alec Fraser, Francesca Bovis, Juan Baeza, Chris McKevitt, Annette Boaz, Peter Heuschmann, Charles D.A. Wolfe, Domenico Inzitari, The European Implementation Score Collaboration Study Group Coinvestigators, Vincent Thijs, Anthony Rudd, Annette Boaz, Maurice Giroud, Yannick Bejot, Silke Wiedmann, Peter Hermanek, Markus Wagner, Marzia Baldereschi, Maria Lamassa, Ilaria Romani, Patrizia Nencini, Daiva Rastenyte, Danuta Ryglewicz, Anna Czlonkowska, Maciej Niewada, Martin Dennis, Miquel Gallofré, Sonia Abilleira, Jaime Masjuan, Bo Norrving and Kjell Asplund and on behalf of the European Implementation Score Collaboration Study Group

Background and Purpose: Differences in stroke care and outcomes reported in Europe may reflect different degrees of implementation of evidence-based interventions. We evaluated strategies for implementing research evidence into stroke care in 10 European countries.

01 agosto 2015

STROKE. Predictors of Mortality in Acute Ischemic Stroke Intervention. Analysis of the North American Solitaire Acute Stroke Registry

Italo Linfante, Gail R. Walker, Alicia C. Castonguay, Guilherme Dabus, Amy K. Starosciak, Albert J. Yoo, Alex Abou-Chebl, Gavin W. Britz, Franklin A. Marden, Alexandria Alvarez, Rishi Gupta, Chun-Huan J. Sun, Coleman Martin, William E. Holloway, Nils Mueller-Kronast, Joey D. English, Tim W. Malisch, Hormozd Bozorgchami, Andrew Xavier, Ansaar T. Rai, Michael T. Froehler, Aamir Badruddin, Thanh N. Nguyen, M. Asif Taqi, Michael G. Abraham, Vallabh Janardhan, Hashem Shaltoni, Roberta Novakovic, Peng R. Chen, Ritesh Kaushal, Ashish Nanda, Mohammad A. Issa, Raul G. Nogueira and Osama O. Zaidat

Background and Purpose: Failure to recanalize predicts mortality in acute ischemic stroke. In the North American Solitaire Acute Stroke registry, we investigated parameters associated with mortality in successfully recanalized patients.

01 agosto 2015

STROKE. Chronic Kidney Disease in Patients With Lacunar Stroke. Association With Enlarged Perivascular Spaces and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease

Lulu Xiao, Wenya Lan, Wen Sun, Qiliang Dai, Yunyun Xiong, Ling Li, Yan Zhou, Ping Zheng, Wenping Fan, Nan Ma, Zhiliang Guo, Xin Chen, Xia Xie, Lili Xu, Wusheng Zhu, Gelin Xu and Xinfeng Liu

Background and Purpose: The relationship between chronic kidney disease and cerebral small vessel disease (cSVD), especially enlarged perivascular spaces (EPVS), has not been fully understood. This study aimed to investigate the association of chronic kidney disease and EPVS, as well as the total burden of cSVD on magnetic resonance imaging, expressed by the simultaneous presence of multiple markers of cSVD, among patients with first-ever lacunar stroke.

10 diciembre 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update

J. Ramalho, R.C. Semelka, M. Ramalho, R.H. Nunes, M. AlObaidy and M. Castillo

SUMMARY: In current practice, gadolinium-based contrast agents have been considered safe when used at clinically recommended doses in patients without severe renal insufficiency. The causal relationship between gadolinium-based contrast agents and nephrogenic systemic fibrosis in patients with renal insufficiency resulted in new policies regarding the administration of these agents. After an effective screening of patients with renal disease by performing either unenhanced or reduced-dose-enhanced studies in these patients and by using the most stable contrast agents, nephrogenic systemic fibrosis has been largely eliminated since 2009. Evidence of in vivo gadolinium deposition in bone tissue in patients with normal renal function is well-established, but recent literature showing that gadolinium might also deposit in the brain in patients with intact blood-brain barriers caught many individuals in the imaging community by surprise. The purpose of this review was to summarize the literature on gadolinium-based contrast agents, tying together information on agent stability and animal and human studies, and to emphasize that low-stability agents are the ones most often associated with brain deposition.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.